<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs001002.v1.p1" parentStudy="phs001002.v1.p1" createDate="2015-10-08" modDate="2015-10-08">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Howard McLeod</td><td>Moffitt Cancer Center, Tampa, FL, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Metastatic Castration-resistant Prostate Cancer GWAS</StudyNameEntrez>
	<StudyNameReportPage>A Genome-Wide Association Study of CALGB 90401: Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone with or without Bevacizumab in Men with Metastatic Castration-Resistant Prostate Cancer</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Cancer and Leukemia Group B (CALGB) 90401 trial compared docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer. A genome-wide association study using clinical outcomes and toxicities was conducted on the basis of data from CALGB patients who provided consent for pharmacogenomic studies and usable DNA</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>CALGB 90401 enrolled 1050 men with metastatic castration-resistant prostate cancer between 2005 and 2007. Among these, 811 patients provided consent for pharmacogenomics studies and usable DNA. The number of patients successfully genotyped was 810.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="22454414"/>
		</Publication>
		<Publication>
			<Pubmed pmid="25417775"/>
		</Publication>
		<Publication>
			<Journal authors="Hertz DL, Owzar K, Halabi S, Kelly WK, Zembutsu H, Jiang C, 			Patel JN, Watson D, Shterev I, Kroetz DL, Friedman PN, Mahoney JF, 			Carducci MA, Kelley MJ, Small EJ, Febbo PG, Nakamura Y, Kubo M, Ratain MJ, McLeod HL" title="A Genome-Wide Association Study (GWAS) of Docetaxel-Induced Peripheral Neuropathy in CALGB 90401 (Alliance)" journal="2013 ASCO Annual Meeting, J Clin Oncol 31, 2013 (suppl; abstr 11053)"/>
		</Publication>
		<Publication>
			<Journal authors="Hertz DL, Jiang C, Owzar K, Halabi S,  Kelly WK, Mulkey F, Patel JN, Carducci MA,  Kelley MJ, Stadler WM, Mohamed MK, 			Morris MJ, Nakamura Y, Zembutsu H, Ratain MJ, McLeod HL" title="A Genome-Wide Association Study (GWAS) of Docetaxel-Induced Neutropenia in CALGB 90401/60404 (Alliance)" journal="2014 ASCO Annual Meeting, J Clin Oncol 32:5s, 2014 (suppl; abstr 9612)"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Prostatic Neoplasms"/>
		<Disease vocab_source="MESH" vocab_term="Neutropenia"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Howard McLeod</AttName>
			<Institution>Moffitt Cancer Center, Tampa, FL, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>CALGB 90401 opened to accrual on April15, 2005 and closed on December 21, 2007. The genotyping was conducted at the Center for Genomic Medicine at the RIKEN Institute in Yokohama Japan.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMB" longName="Health/Medical/Biomedical"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIGMS</DacName>
      <DacFullName>National Institute of General Medical Sciences DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs001002.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001002.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs001002.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health/Medical/Biomedical</ConsentName>
        <ConsentAbbrev>HMB</ConsentAbbrev>
        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
